Biotoxtech Co., Ltd. (KOSDAQ:086040)

South Korea flag South Korea · Delayed Price · Currency is KRW
2,925.00
-195.00 (-6.25%)
At close: May 20, 2026
Market Cap45.98B +0.3%
Revenue (ttm)47.02B +13.7%
Net Income1.16B
EPS74.43
Shares Out15.72M
PE Ratio39.30
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume56,578
Average Volume113,891
Open3,060.00
Previous Close3,120.00
Day's Range2,840.00 - 3,100.00
52-Week Range2,470.00 - 4,115.00
Beta0.55
RSI37.38
Earnings DateMar 27, 2026

About Biotoxtech

Biotoxtech Co., Ltd. engages in the safety evaluation of synthetic medicines, biomedicines, cell therapy products, gene therapy products, health functional foods, chemicals, and pesticides in South Korea. It is involved in testing and substance screening, clinical pathology and histopathology work, and consulting and government affairs related to non-clinical trials, as well as new drug development. The company’s safety evaluation research field includes general toxicity test, carcinogenicity studies, local toxicity studies, reproductive and de... [Read more]

Industry Medical Laboratories
Founded 2000
Employees 188
Stock Exchange KOSDAQ
Ticker Symbol 086040
Full Company Profile

Financial Performance

Financial Statements